Submit a Revision

*your email :**
page name* : such as "Introduction", "Conclusion"..etc
<div><strong>THE PARAMETERS OF INFORMED CONSENT</strong></div> <p><strong>Edward L Raab, MD JD <sup></sup><sup>§</sup></strong></p> <div><em>From the Department of Ophthalmology, Mount Sinai School of Medicine of New York University, New York.</em></div> <p><em></em></p> <p><em></em></p> <p><em></em></p> <div><em></em></div> <p><em></em></p> <p><em></em></p> <div><a></a><em><sup></sup>Presenter</em></div> <div><a></a><em><sup>§</sup>AOS member.</em></div> <div> <div><a></a><strong></strong></div> <div></div> <div> <div><strong>Purpose</strong></div> To describe the components of a proper informed consent; which risks must be disclosed and which need not; additional safeguards for incapacitated persons, minors, and research subjects; and where the law will imply consent that is not otherwise obtained. <p> </p> <div><strong>Methods</strong></div> Summarization of current law obtained from legal treatises, reports of recent cases, and personal experience as a reviewer and expert. <p> </p> <div><strong>Results</strong></div> Lack of informed consent can reinforce a claim of medical malpractice or serve as an alternative point of attack when the case is otherwise weak. Special requirements must be met when patients are the subjects of clinical research. <p> </p> <div><strong>Conclusion</strong></div> Demonstration of a well-conducted process, not merely of a paper, not only protects the physician from exposure to liability, but increases the patient’s autonomy in decisions concerning health and encourages compliance with treatment.</div> <div></div> <div><em></em></div> <div><em>Source: Trans Am Ophthalmol Soc. 2004 December; 102: 225–232.</em></div> </div>
Confirmation code: Enter the code exactly as it appears. All letters are case insensitive, there is no zero.